glp 1 in europe GLP-1 Uptake by Country: Where Ozempic and Mounjaro are Booming 2026 Swiss Re says GLP-1 drugs

However, their popularity has surged beyond traditional endocrinology clinics

Resveratrol for weight loss in obesity: an assessment of randomized control trial designs in ClinicalTrials.gov

Structure of Arg34Lys26-(N-epsilon;-(gamma;-Glu(N-alpha;-hexadecanoyl)))-GLP-1(7-37) Liraglutide peptide shares about 97% sequence identity with human GLP-1 but contains specific modifications that improve its pharmacological stability and duration

These medicines are great for managing blood sugar and losing weight

Market Size & Growth Forecasts The global GLP-1 analogues market is estimated at $66.48 billion in 2025, projected to skyrocket to $879.9 billion by 2034, representing an impressive CAGR of ~33.2% Another source estimates the broader GLP-1 market at $47.74 billion in 2024, with a more conservative CAGR of 10.9% from 20252034